These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23686300

  • 1. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
    Oflaz MB, Balli S, Kibar AE, Ece I, Akdeniz C, Tuzcu V.
    Med Sci Monit; 2013 May 15; 19():366-72. PubMed ID: 23686300
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1926-34. PubMed ID: 10362195
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J, Margossian R, Darras BT, Colan SD, Jenkins KJ, Geva T, Powell AJ.
    Pediatr Cardiol; 2008 Mar 15; 29(2):343-51. PubMed ID: 17885779
    [Abstract] [Full Text] [Related]

  • 8. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C, Acar P, Sidi D.
    Eur J Nucl Med Mol Imaging; 2003 Dec 15; 30(12):1651-6. PubMed ID: 14504829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
    Tsuda E, Negishi J, Noritake K, Iwasa T, Abe T.
    J Cardiol; 2016 Feb 15; 67(2):147-52. PubMed ID: 26572957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H, Bohlmann M, Eck U, Petersen B, Rödiger W.
    Eur J Heart Fail; 2000 Mar 15; 2(1):71-9. PubMed ID: 10742706
    [Abstract] [Full Text] [Related]

  • 16. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 17. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Tange S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2004 Nov 01; 45(11):1878-84. PubMed ID: 15534058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.